These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29668740)

  • 21. Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model.
    Olmsted SS; Khanna KV; Ng EM; Whitten ST; Johnson ON; Markham RB; Cone RA; Moench TR
    BMC Infect Dis; 2005 Sep; 5():79. PubMed ID: 16194280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA; Baxter C
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):13-23. PubMed ID: 23428099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides.
    Neurath AR; Strick N; Li YY
    BMC Infect Dis; 2006 Oct; 6():150. PubMed ID: 17042959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection.
    Vibholm L; Reinert LS; Søgaard OS; Paludan SR; Østergaard L; Tolstrup M; Melchjorsen J
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1404-11. PubMed ID: 22867119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission.
    Sepúlveda-Crespo D; Sánchez-Rodríguez J; Serramía MJ; Gómez R; De La Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
    Nanomedicine (Lond); 2015; 10(6):899-914. PubMed ID: 25867856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Antiretroviral Microbicides for HIV Prevention.
    Scott Y; Dezzutti CS
    AIDS Rev; 2016; 18(3):145-150. PubMed ID: 27438574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.
    Bártolo I; Diniz AR; Borrego P; Ferreira JP; Bronze MR; Barroso H; Pinto R; Cardoso C; Pinto JF; Diaz RC; Broncano PG; Muñoz-Fernández MA; Taveira N
    PLoS One; 2018; 13(5):e0197015. PubMed ID: 29718988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and evaluation of mucoadhesive bigel containing tenofovir and maraviroc for HIV prophylaxis.
    Ilomuanya MO; Hameedat AT; Akang EN; Ekama SO; Silva BO; Akanmu AS
    Futur J Pharm Sci; 2020; 6(1):81. PubMed ID: 33241057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide.
    Sassi AB; Bunge KE; Hood BL; Conrads TP; Cole AM; Gupta P; Rohan LC
    AIDS Res Ther; 2011 Jul; 8():27. PubMed ID: 21801426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques.
    Tsai CC; Emau P; Jiang Y; Tian B; Morton WR; Gustafson KR; Boyd MR
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):535-41. PubMed ID: 12921090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.
    Ham AS; Nugent ST; Peters JJ; Katz DF; Shelter CM; Dezzutti CS; Boczar AD; Buckheit KW; Buckheit RW
    Antiviral Res; 2015 Aug; 120():153-64. PubMed ID: 26093158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission.
    Vacas Córdoba E; Arnaiz E; Relloso M; Sánchez-Torres C; García F; Pérez-Álvarez L; Gómez R; de la Mata FJ; Pion M; Muñoz-Fernández MÁ
    AIDS; 2013 May; 27(8):1219-29. PubMed ID: 23925376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits.
    Aranha CC; Gupta SM; Reddy KV
    Cytokine; 2008 Jul; 43(1):63-70. PubMed ID: 18513989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission.
    Ariën KK; Venkatraj M; Michiels J; Joossens J; Vereecken K; Van der Veken P; Abdellati S; Cuylaerts V; Crucitti T; Heyndrickx L; Heeres J; Augustyns K; Lewi PJ; Vanham G
    J Antimicrob Chemother; 2013 Sep; 68(9):2038-47. PubMed ID: 23645585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilization and Sustained Release of HIV Inhibitors by Encapsulation in Silk Fibroin Disks.
    Zhang L; Herrera C; Coburn J; Olejniczak N; Ziprin P; Kaplan DL; LiWang PJ
    ACS Biomater Sci Eng; 2017; 3(8):1654-1665. PubMed ID: 33225060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients.
    Rossetti B; Montagnani F; De Luca A
    Expert Opin Pharmacother; 2018 May; 19(7):713-738. PubMed ID: 29676935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.
    Rodríguez-Izquierdo I; Sepúlveda-Crespo D; Lasso JM; Resino S; Muñoz-Fernández MÁ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1774. PubMed ID: 35018739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.